Breast cancer incidence (invasive) statistics

Cases

New cases of breast cancer, 2014-2016 average, UK

 

Proportion of all cases

Percentage breast cancer is of total cancer cases, 2014-2016 average, UK

 

Age

Peak rate of breast cancer cases, 2014-2016, UK

Trend over time

Breast cancer incidence rates have changed differently for each sex since the early 1990s, UK

 

Breast cancer is the most common cancer in the UK, accounting for 15% of all new cancer cases (2016).[1-4]

In females in the UK it is the most common cancer (31% of all new female cancer cases). In males in the UK, breast cancer is not among the 20 most common cancers (less than 1% of all new male cancer cases).

99% of breast cancer cases in the UK are in females, and 1% are in males.

Breast cancer incidence rates (European age-standardised (AS) rates Open a glossary item) are similar to the UK average in all the UK constituent countries.

Breast Cancer (C50), Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, UK, 2016

  England Scotland Wales Northern Ireland UK
Female Cases 45,655 4,619 2,830 1,437 54,541
Crude Rate 163.2 166.3 179.2 151.8 163.9
AS Rate 167.9 162.6 171.1 164.6 167.6
AS Rate - 95% LCL 166.4 157.9 164.8 156.1 166.1
AS Rate - 95% UCL 169.5 167.3 177.4 173.1 169.0
Male Cases 304 21 21 9 355
Crude Rate 1.1 0.8 1.4 1.0 1.1
AS Rate 1.3 0.9 1.4 1.3 1.3
AS Rate - 95% LCL 1.2 0.5 0.8 0.4 1.1
AS Rate - 95% UCL 1.4 1.3 2.1 2.1 1.4
Persons Cases 45,959 4,640 2,851 1,446 54,896
Crude Rate 83.2 85.9 91.6 77.7 83.6
AS Rate 88.8 87.4 90.8 87.7 88.7
AS Rate - 95% LCL 88.0 84.8 87.5 83.2 88.0
AS Rate - 95% UCL 89.6 89.9 94.1 92.2 89.5

95% LCL and 95% UCL are the 95% lower and upper confidence limits Open a glossary item  around the AS Rate Open a glossary item 

See also

Breast cancer mortality statistics by sex and UK country

Cancer incidence for common cancers in the UK

References

  1. Data were provided by the National Cancer Registration and Analysis Service (part of Public Health England), on request through the Office for Data Release, August 2018. Similar data can be found here: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/previousReleases
  2. Data were provided by ISD Scotland on request, April 2018. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications.
  3. Data were provided by the Welsh Cancer Intelligence and Surveillance Unit, Health Intelligence Division, Public Health Wales on request, February 2019. Similar data can be found here: http://www.wcisu.wales.nhs.uk.
  4. Data were provided by the Northern Ireland Cancer Registry on request, April 2018. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 2016, ICD-10 C50.

Last reviewed:

Breast cancer incidence is strongly related to age, with the highest incidence rates being in older people. In the UK in 2014-2016, on average each year a quarter (25%) of new cases were in people aged 75 and over.[1-4]

Age-specific incidence rates rise steadily from around age 30-34 and more steeply from around age 70-74. The highest rates are in the 85 to 89 age group for females and the 90+ age group for males.

Incidence rates are significantly higher in females than males in a number of (mainly older) age groups. The gap is widest at age 45 to 49, when the age-specific incidence rate is 480 times higher in females than males.

Breast Cancer (C50), Average Number of New Cases per Year and Age-Specific Incidence Rates per 100,000 Population, Females, UK, 2014-2016

95% LCL and 95% UCL are the 95% lower and upper confidence limits Open a glossary item  around the AS Rate Open a glossary item

Breast Cancer (C50), Average Number of New Cases per Year and Age-Specific Incidence Rates per 100,000 Population, Males, UK, 2014-2016

95% LCL and 95% UCL are the 95% lower and upper confidence limits Open a glossary item  around the AS Rate Open a glossary item
 

For female breast cancer, like other cancer types with a screening programme, incidence increases rapidly at the age screening starts, as prevalent cases are identified. Incidence then tends to return to the usual pattern of gradual increase with age – as seen for male breast cancer. This largely reflects cell DNA damage accumulating over time. Damage can result from biological processes or from exposure to risk factors. A drop or plateau in incidence in the oldest age groups often indicates reduced diagnostic activity perhaps due to general ill health.

See also

Breast cancer (in situ) incidence statistics by age

Breast cancer mortality statistics by age

Breast cancer survival statistics by age

Cancer incidence statistics by age for all cancers

References

  1. Data were provided by the National Cancer Registration and Analysis Service (part of Public Health England), on request through the Office for Data Release, August 2018. Similar data can be found here: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/previousReleases
  2. Data were provided by ISD Scotland on request, April 2018. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications.
  3. Data were provided by the Welsh Cancer Intelligence and Surveillance Unit, Health Intelligence Division, Public Health Wales on request, February 2019. Similar data can be found here: http://www.wcisu.wales.nhs.uk.
  4. Data were provided by the Northern Ireland Cancer Registry on request, April 2018. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 2014-2016, ICD-10 C50.

Last reviewed:

Breast cancer European age-standardised (AS) Open a glossary item incidence rates for females and males combined increased by 19% in the UK between 1993-1995 and 2014-2016.[1-4] The change varied markedly between sexes.

For females, breast cancer AS incidence rates in the UK increased by 24% between 1993-1995 and 2014-2016. For males, breast cancer AS incidence rates in the UK remained stable between 1993-1995 and 2014-2016.

Over the last decade in the UK (between 2004-2006 and 2014-2016), breast cancer AS incidence rates for females and males combined increased by 4%.[1-4] In females AS incidence rates increased by 6%, and in males rates remained stable.

Breast Cancer (ICD-10 C50), European Age-Standardised Incidence Rates, UK, 1993-2016

Breast Cancer (ICD-10 C50), European Age-Standardised Incidence Rates, Males, UK, 1993-2016

Breast cancer incidence rates have increased overall in all broad adult age groups in females in the UK since the early 1990s.[1-4] Rates in 25-49s have increased by 17%, in 50-64s have increased by 14%, in 65-69s have increased by 70%, in 70-79s have increased by 32%, and in 80+s have increased by 22%.

Breast Cancer (ICD-10 C50), European Age-Standardised Incidence Rates, By Age, Females, UK, 1993-2016

Breast cancer incidence rates have remained stable overall in all broad adult age groups in males in the UK since the early 1990s.[1-4] Rates in 25-49s have remained stable, in 50-64s have remained stable, in 65-69s have remained stable, in 70-79s have remained stable, and in 80+s have remained stable.

Breast Cancer (ICD-10 C50), European Age-Standardised Incidence Rates, By Age, Males, UK, 1993-2016​

For breast cancer, like most cancer types, incidence trends largely reflect changing prevalence of risk factors and improvements in diagnosis and data recording. Recent incidence trends are influenced by risk factor prevalence in years past, and trends by age group reflect risk factor exposure in birth cohorts.

The introduction of the breast screening programmes in the late-1980s also plays a part for females.

See also

Breast cancer (in situ) incidence trends over time

Breast cancer mortality trends over time

Breast cancer survival trends over time

Cancer incidence trends over time for all cancers in the UK

References

  1. Data were provided by the National Cancer Registration and Analysis Service (part of Public Health England), on request through the Office for Data Release, August 2018. Similar data can be found here: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/previousReleases
  2. Data were provided by ISD Scotland on request, April 2018. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications.
  3. Data were provided by the Welsh Cancer Intelligence and Surveillance Unit, Health Intelligence Division, Public Health Wales on request, February 2019. Similar data can be found here: http://www.wcisu.wales.nhs.uk.
  4. Data were provided by the Northern Ireland Cancer Registry on request, April 2018. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 1993-2016, ICD-10 C50.

Last reviewed:

Overall stage at diagnosis

A high proportion (89-97%) of breast cancer cases in England, Scotland and Northern Ireland have a stage at diagnosis recorded.[1-3]

More breast cancer patients with a known stage are diagnosed at an early stage (79-87% are diagnosed at stage I or II), than a late stage (13-21% are diagnosed at stage III or IV). Between 6% and 7% of people have metastases at diagnosis (stage IV).[1-3]

The stage distribution for each cancer type will reflect many factors including how the cancer type develops, the way symptoms appear, public awareness of symptoms, how quickly a person goes to see their doctor and how quickly the cancer is recognised and diagnosed by a doctor. It might also relate to whether a national screening programme that can detect early stage disease exists for that cancer type, along with the extent of uptake of that programme.

A cancer type associated with a large proportion of early stage diagnoses could be one that is more likely to be symptomatic at an earlier stage of development, with recognisable symptoms rather than more generic ones.

Breast Cancer (C50), Proportion of Cases Diagnosed at Each Stage, All Ages, England 2014, Scotland 2014-2015 and Northern Ireland 2010-2014

Data should not be compared between countries due to differences in time periods and possible differences in recording of stage at diagnosis.

Stage at diagnosis by deprivation

Late stage at diagnosis of breast cancer in England is associated with higher deprivation. Among adults aged 15-99 in England, 20% of those in the most deprived areas are diagnosed at stage III or IV, versus 15% of those in the least deprived areas.[4]

Stage at diagnosis by age

Late stage at diagnosis of breast cancer in England is more common in older adults (aged 80+) in England (23%), compared to those aged 60-79 (15%) and aged 15-59 (16%).[4]

There is no difference between late stage at diagnosis for breast cancer between those aged 60-79 and 15-59 in England.[4]

These patterns by deprivation, age and sex are probably not explained by other demographic differences.[5]

Stage at diagnosis by Ethnicity

Late stage at diagnosis for breast cancer in England is more common in Black African (25%) and Black Caribbean adults (22%), compared to White British adults (13%) after adjusting for age, sex and deprivation.[6]

See also

View our patient information on staging for breast cancer

Breast cancer survival by stage at diagnosis

More about incidence by stage data collection and quality

Routes to diagnosis

Deprivation gradient in breast cancer incidence

References

  1. National Cancer Registration and Analysis Service. Stage Breakdown by CCG 2014. London: NCIN; 2016.
  2. ISD Scotland, Detect Cancer Early Staging Data. Scotland: ISD; 2016
  3. Northern Ireland Cancer Registry, Queens University Belfast. Incidence by stage 2010-2014. Belfast: NICR; 2016.
  4. National Cancer Registration and Analysis Service. Routes to diagnosis of cancer by stage 2012-2013 workbook. London: NCRAS; 2016
  5. Lyratzopoulos G, Abel G, Brown C, et al. Socio-demographic inequalities in stage of cancer diagnosis: evidence from patients with female breast, lung, colon, rectal, prostate, renal, bladder, melanoma, ovarian and endometrial cancer. Annals of Oncology, 2012:843-50.
  6. National Cancer Registration and Analysis Service. Ethnicity and stage at diagnosis. London: NCRAS; 2016

About this data

Data is for : England 2014, Scotland 2014-2015, Northern Ireland 2010-2014, ICD-10 C50 (overall stage at diagnosis) and England, 2012-2013, ICD-10 C50 (stage at diagnosis by deprivation, age, sex, and ethnicity)

Data is not comparable between countries due to differences in time periods and possible differences in how countries record stage at diagnosis.

The proportions of patients diagnosed late only include cases with a known stage at diagnosis and are not adjusted for other demographics differences (e.g. age, sex, ethnicity) unless stated otherwise.

Last reviewed:

The largest proportion of breast cancer cases occur in the upper-outer quadrant of the breast, with much smaller proportions in the upper-inner, lower-outer and lower-inner quadrants, and the central portion of the breast (2010-2012).[1-4]

More than half (51.9%) of cases did not have the specific part of the breast recorded in cancer registry data, or overlapped more than one part.[1-4]

Cases and percentages may not sum due to rounding

See also

Find out more about the counting and coding of this data

In situ breast carcinoma incidence by anatomical site

References

  1. Data were provided by the Office for National Statistics on request, July 2014. Similar data can be found here: http://www.ons.gov.uk/ons/rel/vsob1/cancer-statistics-registrations--england--series-mb1-/index.html.
  2. Data were provided by ISD Scotland on request, April 2014. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp.
  3. Data were provided by the Welsh Cancer Intelligence and Surveillance Unit on request, April 2014. Similar data can be found here: http://www.wales.nhs.uk/sites3/page.cfm?orgid=242&pid=59080.
  4. Data were provided by the Northern Ireland Cancer Registry on request, June 2014. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/CancerInformation/.

About this data

Data is for UK, 2010-2012, ICD-10 C50.

Last reviewed:

Breast cancer incidence rates are projected to rise by 2% in the UK between 2014 and 2035, to 210 cases per 100,000 females by 2035.[1]

Breast cancer (C50), Observed and Projected Age-Standardised Incidence Rates, by Sex, UK, 1979-2035

Download the data table (xls)

It is projected that 71,022 cases of breast cancer will be diagnosed in the UK in 2035.

See also

Find out how these projections were calculated

Incidence trends over time for breast cancer

Projections of incidence for all cancers combined

Breast cancer risk

Download the projections data table

References

  1. Smittenaar CR, Petersen KA, Stewart K, Moitt N. Cancer Incidence and Mortality Projections in the UK Until 2035. Brit J Cancer 2016.

About this data

Data is for: UK, 1979-2014 (observed), 2015-2035 (projected), ICD-10 C50

Projections are based on observed incidence and mortality rates and therefore implicitly include changes in cancer risk factors, diagnosis and treatment. It is not possible to assess the statistical significance of changes between 2014 (observed) and 2035 (projected) figures. Confidence intervals are not calculated for the projected figures. Projections are by their nature uncertain because unexpected events in future could change the trend. It is not sensible to calculate a boundary of uncertainty around these already uncertain point estimates. Changes are described as 'increase' or 'decrease' if there is any difference between the point estimates.

More on projections methodology

Last reviewed:

There is evidence for a small association between female breast cancer incidence and deprivation in England, with breast cancer being one of the few cancers where incidence rates are lower for more deprived females.[1] England-wide data for 2006-2010 show European age-standardised Open a glossary item incidence rates are 14% lower for females living in the most deprived areas compared with the least deprived.[1]

Breast Cancer (C50), European Age-Standardised Incidence Rates by Deprivation Quintile, Females, England, 2006-2010

The estimated deprivation gradient in breast cancer incidence between females living in the most and least deprived areas in England has not changed in the period 1996-2010. It has been estimated that there would have been around 1,900 more breast cancer cases each year in England during 2006-2010 if all females experience the same incidence rates as the least deprived.[1]

There is no evidence for an association between breast cancer incidence and deprivation in males in England.[1] England-wide data for 2006-2010 show European age-standardised incidence rates are similar for males living in the most deprived areas compared with the least deprived.[1]

Breast Cancer (C50), European Age-Standardised Incidence Rates by Deprivation Quintile, Males, England, 2006-2010

The estimated deprivation gradient in breast cancer incidence between males living in the most and least deprived areas in England has not changed in the period 1996-2010.[1]

See also

Deprivation gradient for cancer incidence

Deprivation gradient in in situ breast carcinoma incidence

Deprivation gradient in breast cancer mortality

Breast cancer survival statistics by socio-economic group

Socio-economic variation in cancer incidence for Scotland

Socio-economic variation in cancer incidence for Wales

Socio-economic variation in cancer incidence for Northern Ireland

References

  1. Cancer Research UK and National Cancer Intelligence Network. Cancer by deprivation in England: Incidence, 1996-2010, Mortality, 1997-2011. London: NCIN; 2014.  

About this data

Data is for UK, 2006-2010, ICD-10 C50

Deprivation gradient statistics were calculated using incidence data for 2006-2010. The deprivation quintiles were calculated using the Income domain scores from the Index of Multiple Deprivation (IMD) from the following years: 2004, 2007 and 2010. Full details on the data and methodology can be found in the Cancer by Deprivation in England NCIN report.

Last reviewed:

Age-standardised Open a glossary item rates for White females with breast cancer range from 122.4 to 125.7 per 100,000. Rates for Asian females are significantly lower, ranging from 59.7 to 92.3 per 100,000 and the rates for Black females are also significantly lower, ranging from 68.8 to 107.9 per 100,000.[1]

Ranges are given because of the analysis methodology used to account for missing and unknown data. For female breast cancer, 187,620 cases were identified; 25% had no known ethnicity.

See also

Find out more about the counting and coding of this data

Cancer incidence statistics by ethnicity 

References

  1. National Cancer Intelligence Network (NCIN) and Cancer Research UK. Cancer Incidence and Survival by Major Ethnic Group, England, 2002-2006. London: NCIN; 2009.

About this data

Data is for England, 2002-2006, ICD-10 C50

Last reviewed:

An estimated 491,300 women who had been diagnosed with female breast cancer between 1991 and 2010 were alive in the UK at the end of 2010.[1]

See also

Breast cancer incidence statistics by sex and UK country

What is prevalence?

References

  1. Macmillan Cancer Support and National Cancer Registration and Analysis Service. Cancer Prevalence UK Data Tables. London: NCRAS; 2015.

About this data

Data is for: Great Britain (1991-2010) and Northern Ireland (1993-2010), ICD-10 C50.

Last reviewed:

Male breast cancer incidence rates have remained stable in Great Britain since the late 1970s.[1-3] European age-standardised Open a glossary item (AS) incidence rates remained stable between 1979-1981 and 2011-2013.

Breast Cancer (C50), European Age-Standardised Incidence Rates, Males, Great Britain, 1979-2013

ASR calculated with ESP2013. Not comparable with ASRs calculated with ESP1976.

Over the last decade in the UK (between 2002-2004 and 2011-2013), male breast cancer AS incidence rates have remained stable.[1-4]

Breast Cancer (C50), European Age-Standardised Incidence Rates, Males, UK, 1993-2013

ASR calculated with ESP2013. Not comparable with ASRs calculated with ESP1976.

Male breast cancer incidence rates have remained stable overall for most age groups in Great Britain since the late 1970s.[1-3] The greatest change in incidence rates has been at age 50-59 with rates rising by 53% between 1979-1981 and 2011-2013. Rates in males aged 80+ have fluctuated but overall remained stable since the late 1970s.

Breast Cancer (C50), European Age-Standardised Incidence Rates, Males, by Age, Great Britain, 1979-2013

ASR calculated with ESP2013. Not comparable with ASRs calculated with ESP1976.

See also

Breast cancer mortality in males

Breast cancer risk factors

References

  1. Data were provided by the Office for National Statistics on request, July 2015. Similar data can be found here: http://www.ons.gov.uk/ons/rel/vsob1/cancer-statistics-registrations--england--series-mb1-/index.html.
  2. Data were provided by ISD Scotland on request, April 2015. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp#605
  3. Data were provided by the Welsh Cancer Intelligence and Surveillance Unit on request, February 2015. Similar data can be found here: http://www.wales.nhs.uk/sites3/page.cfm?orgid=242&pid=51358
  4. Data were provided by the Northern Ireland Cancer Registry on request, March 2015. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/
  5. National Cancer Intelligence Network (NCIN). One, Five and Ten Year Cancer Prevalence by Cancer Network, UK, 2006. London: NCIN; 2010. 

About this data

Data is for: 1993-2013 (UK) and 1979-2013 (Great Britain), Males, ICD-10 C21

Last reviewed:

Cancer stats explained

See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.

Cancer stats explained

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, Angel Building, 407 St John Street, London, EC1V 4AD or

Donate online

We’re now on twitter.

Join the conversation and follow @TalkCancer_CRUK for news, updates and opinion.

@TalkCancer_CRUK

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.